Drugs / ETD002
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04488705 | Aug 2020 → May 2021 | — | Enterprise Therapeutics Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ETD002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04488705 ↗ |
| Route | Inhaled | “inhaled ETD002” NCT04488705 ↗ |